You're signed outSign in or to get full access.
Biotech and Biopharma Associate at Wells Fargo
Hao Shen is a Biotech and Biopharma Associate at Wells Fargo, specializing in biotechnology and biopharmaceutical sector research. Specific companies covered and performance metrics are not publicly detailed in available sources. Shen previously served as a Biotech and Biopharma Analyst, with limited information on exact career timeline or previous firms; he is based in San Francisco, California. Professional credentials such as FINRA registrations or securities licenses are not specified in available data.
Hao Shen asked about the timing and expected data/events for Kymera's potential oral autoantibody degrader program, referring to a new internal program.
CEO Nello Mainolfi clarified that Kymera plans to disclose at least one new novel program, most likely an immunology program, in the second half of the current year.
Fintool can predict 
KYMR's earnings beat/miss a week before the call